by Rakovina Therapeutics | Oct 14, 2026 | Uncategorized
DOWNLOAD Agreement provides Rakovina exclusive access to its optimized kt-5000 target profile and extends AI-powered lead optimization through year-end at no additional cost VANCOUVER, British Columbia, October 14, 2026 (GLOBE NEWSWIRE) – Rakovina Therapeutics Inc....
by Rakovina Therapeutics | Oct 1, 2026 | Uncategorized
DOWNLOAD Collaboration to identify optimal combination therapies, predictive biomarkers and patient populations for Rakovina’s ATR inhibitor program VANCOUVER, British Columbia, October 1, 2026 (GLOBE NEWSWIRE) – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0)...
by Rakovina Therapeutics | Sep 18, 2026 | Uncategorized
DOWNLOAD Yale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics VANCOUVER, British Columbia, September 17, 2026 (GLOBE NEWSWIRE) – Rakovina Therapeutics Inc. (TSX-V:...
by Rakovina Therapeutics | Sep 10, 2026 | Uncategorized
DOWNLOAD Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company’s Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, September 10, 2026 (GLOBE NEWSWIRE) —...
by Rakovina Therapeutics | Aug 31, 2026 | Uncategorized
DOWNLOAD Financing completed at the full upsized amount following strong investor demand VANCOUVER, British Columbia, August 31, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer...
by Rakovina Therapeutics | Aug 31, 2026 | Uncategorized
VANCOUVER, British Columbia, August 19, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce the results of voting...